Michael Scolaro

Michael Scolaro

Sep 08, 2017

Group 6 Copy 215
-1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

Exploring an age-old question: Can we demystify skin color?

In 2005, our lab uncovered one of the most pervasive genetic mutations on SLC24A5, the contributor to the...

Nutritional analysis of cold-climate perennial vegetables

Perennial vegetables are edible plants that regrow in the same place every year. They are a key component...

Backer Badge Funded